Electron microscopy analysis of a disaccharide analog complex reveals receptor interactions of adeno-associated virus

Journal of Structural Biology

Volumn 184, Issue 2, 2013, Pages 129-135

  Xie, Qing ^a   Spilman, Michael ^b   Meyer, Nancy L ^a   Lerch, Thomas F ^a   Stagg, Scott M ^b   Chapman, Michael S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Attachment; Difference map; Heparin; Parvovirus; Receptor; Refinement

Indexed keywords

ARGININE; DISACCHARIDE; HEPARIN; PARVOVIRUS VECTOR; SUCROSOFATE;

ADENO ASSOCIATED VIRUS; ARTICLE; BINDING SITE; CARBOHYDRATE ANALYSIS; CELL SPECIFICITY; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; ELECTRON MICROSCOPY; INSECT CELL; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; STEREOCHEMISTRY; VIRAL GENE THERAPY; VIRUS ATTACHMENT; VIRUS LIKE AGENT; VIRUS TRANSFORMATION; X RAY CRYSTALLOGRAPHY;

ADENO-ASSOCIATED VIRUS; PARVOVIRUS;

AAV; ADENO-ASSOCIATED VIRUS; ATTACHMENT; CONTRAST TRANSFER FUNCTION; CTF; DIFFERENCE MAP; ELECTRON MICROSCOPY; EM; FOURIER SHELL CORRELATION; FSC; HBD; HEPARAN SULFATE PROTEOGLYCAN; HEPARIN; HEPARIN-BINDING DOMAIN; HSPG; PARVOVIRUS; RECEPTOR; REFINEMENT; VIRUS-LIKE PARTICLE; VLP;

BINDING SITES; CAPSID PROTEINS; CELLS, CULTURED; CRYOELECTRON MICROSCOPY; DEPENDOVIRUS; DISACCHARIDES; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; RECEPTORS, VIRUS; VIRION;

EID: 84887231402     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2013.09.004     Document Type: Article

References (71)

1. Akache B., Grimm D., Pandey K., Yant S.R., Xu H., et al. The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J. Virol. 2006, 80:9831-9836.
2. Asokan A., Hamra J.B., Govindasamy L., Agbandje-McKenna M., Samulski R.J. Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry. J. Virol. 2006, 80:8961-8969.
3. Asokan A., Conway J.C., Phillips J.L., Li C., Hegge J., et al. Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle. Nat. Biotechnol. 2010, 28:79-82.
4. Asokan A., Schaffer D.V., Samulski R.J. The AAV vector toolkit: poised at the clinical crossroads. Mol. Ther. 2012, 20:699-708.
5. Bai X.C., Fernandez I.S., McMullan G., Scheres S.H. Ribosome structures to near-atomic resolution from thirty thousand cryo-EM particles. elife 2013, 2:e00461.
6. Bartlett J.S., Wilcher R., Samulski R.J. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol. 2000, 74:2777-2785.
7. Bell C.L., Gurda B.L., Van Vliet K., Agbandje-McKenna M., Wilson J.M. Identification of the galactose binding domain of the AAV9 capsid. J. Virol. 2012, 86:7325-7333.
8. Böttcher B., Wynne S.A., Crowther R.A. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 1997, 386:88-91.
9. Brünger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., et al. Crystallography and NMR system: a new software system for macromolecular structure determination. Acta Crystallogr. A 1998, D54:905-921.
10. Carter B.J., Burstein H., Peluso R.W. Adeno-associated virus and AAV vectors for gene delivery. Gene and Cell Therapy: Therapeutic Mechanisms and Strategies 2008, 115-156. CRC Press, Boca Raton. N.S. Templeton (Ed.).
11. Chapman M.S., Trzynka A., Chapman B.K. Atomic modeling of cryo-electron microscopy reconstructions - joint refinement of model and imaging parameters. J. Struct. Biol. 2013, 182:10-21.
12. Choi V.W., McCarty D.M., Samulski R.J. AAV hybrid serotypes: improved vectors for gene delivery. Curr. Gene Ther. 2005, 5:299-310.
13. Conrad H.E. Heparin-Binding Proteins 1998, Academic Press, San Diego. 1st ed.
14. Cotmore S.F., Tattersall P. Parvoviral host range and cell entry mechanisms. Adv. Virus Res. 2007, 70:183-232.
15. DeLano W.L. The PyMOL Molecular Graphics System 2002, DeLano Scientific, San Carlos, CA, USA.
16. DiMattia M.A., Nam H.J., Van Vliet K., Mitchell M., Bennett A., et al. Structural insight into the unique properties of adeno-associated virus serotype 9. J. Virol. 2012, 86:6947-6958.
17. Dimitrov D.S. How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity. Cell 1997, 91:721-730.
18. DiPrimio N., McPhee S.W., Samulski R.J. Adeno-associated virus for the treatment of muscle diseases: toward clinical trials. Curr. Opin. Mol. Ther. 2010, 12:553-560.
19. Emsley P., Lohkamp B., Scott W.G., Cowtan K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 2010, 66:486-501.
20. Fernandez J.J., Luque D., Caston J.R., Carrascosa J.L. Sharpening high resolution information in single particle electron cryomicroscopy. J. Struct. Biol. 2008, 164:170-175.
21. Fry E.E., Lea S.M., Jackson T., Newman J.W., Ellard F.M., et al. The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J. 1999, 18:543-554.
22. Grigorieff N. Resolution measurement in structures derived from single particles. Acta Crystallogr. D Biol. Crystallogr. 2000, 56:1270-1277.
23. Grigorieff N. FREALIGN: high-resolution refinement of single particle structures. J. Struct. Biol. 2007, 157:117-125.
24. Grimm D., Lee J.S., Wang L., Desai T., Akache B., et al. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. J. Virol. 2008, 82:5887-5911.
25. Harauz G., van Heel M. Exact filters for general geometry 3-dimensional reconstruction. Optik 1986, 73:146-156.
26. Hashem Y., des Georges A., Fu J., Buss S.N., Jossinet F., et al. High-resolution cryo-electron microscopy structure of the Trypanosoma brucei ribosome. Nature 2013, 494:385-389.
27. Henderson R., Moffat J.K. The difference fourier technique in protein crystallography: errors and their treatment. Acta Crystallogr. B 1971, 27:1414-1420.
28. Johnson L.N., Phillips D.C. Structure of some crystalline lysozyme-inhibitor complexes determined by X-ray analysis at 6Å resolution. Nature 1965, 206:761-763.
29. Kaludov N., Brown K.E., Walters R.W., Zabner J., Chiorini J.A. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 2001, 75:6884-6893.
30. Kashiwakura Y., Tamayose K., Iwabuchi K., Hirai Y., Shimada T., et al. Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. J. Virol. 2005, 79:609-614.
31. Kern A., Schmidt K., Leder C., Muller O.J., Wobus C.E., et al. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J. Virol. 2003, 77:11072-11081.
32. Lander G.C., Stagg S.M., Voss N.R., Cheng A., Fellmann D., et al. Appion: an integrated, database-driven pipeline to facilitate EM image processing. J. Struct. Biol. 2009, 166:95-102.
33. Lerch T.F., Chapman M.S. Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B). Virology 2012, 423:6-13.
34. Lerch Thomas F., O'Donnell Jason K., Meyer Nancy L., Xie Q., Taylor Kenneth A., et al. Structure of AAV-DJ, a retargeted gene therapy vector: cryo-electron microscopy at 4.5Å resolution. Structure 2012, 20:1310-1320.
35. Levy H.C., Bowman V.D., Govindasamy L., McKenna R., Nash K., et al. Heparin binding induces conformational changes in adeno-associated virus serotype 2. J. Struct. Biol. 2009, 165:146-156.
36. Ludtke S.J., Baldwin P.R., Chiu W. EMAN: semiautomated software for high-resolution single-particle reconstructions. J. Struct. Biol. 1999, 128:82-97.
37. Ludtke S.J., Baker M.L., Chen D.H., Song J.L., Chuang D.T., et al. De novo backbone trace of GroEL from single particle electron cryomicroscopy. Structure 2008, 16:441-448.
38. Maheshri N., Koerber J.T., Kaspar B.K., Schaffer D.V. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat. Biotechnol. 2006, 24:198-204.
39. Mallick S.P., Carragher B., Potter C.S., Kriegman D.J. ACE: automated CTF estimation. Ultramicroscopy 2005, 104:8-29.
40. Mani B., Baltzer C., Valle N., Almendral J.M., Kempf C., et al. Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome. J. Virol. 2006, 80:1015-1024.
41. McCraw D.M., O'Donnell J.K., Taylor K.A., Stagg S.M., Chapman M.S. Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20. Virology 2012, 431:40-49.
42. Mills D.J., Vitt S., Strauss M., Shima S., Vonck J. De novo modeling of the F420-reducing [NiFe]-hydrogenase from a methanogenic archaeon by cryo-electron microscopy. elife 2013, 2:e00218.
43. Milne J.L., Borgnia M.J., Bartesaghi A., Tran E.E., Earl L.A., et al. Cryo-electron microscopy-a primer for the non-microscopist. FEBS J. 2013, 280:28-45.
44. Moriarty N.W., Grosse-Kunstleve R.W., Adams P.D. Electronic ligand builder and optimization workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr. D Biol. Crystallogr. 2009, 65:1074-1080.
45. Nam H.J., Lane M.D., Padron E., Gurda B., McKenna R., et al. Structure of adeno-associated virus serotype 8, a gene therapy vector. J. Virol. 2007, 81:12260-12271.
46. Nam H.J., Gurda B.L., McKenna R., Potter M., Byrne B., et al. Structural studies of adeno-associated virus serotype 8 capsid transitions associated with endosomal trafficking. J. Virol. 2011, 85:11791-11799.
47. Nathwani A.C., Tuddenham E.G., Rangarajan S., Rosales C., McIntosh J., et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N. Engl. J. Med. 2011, 365:2357-2365.
48. O'Donnell J., Taylor K.A., Chapman M.S. Adeno-associated virus-2 and its primary cellular receptor - cryo-EM structure of a heparin complex. Virology 2009, 385:434-443.
49. Opie S.R., Warrington K.H., Agbandje-McKenna M., Zolotukhin S., Muzyczka N. Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. J. Virol. 2003, 77:6995-7006.
50. Patel M., Yanagishita M., Roderiquez G., Bou-Habib D.C., Oravecz T., et al. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res. Hum. Retroviruses 1993, 9:167-174.
51. Perabo L., Goldnau D., White K., Endell J., Boucas J., et al. Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism. J. Virol. 2006, 80:7265-7269.
52. Qing K., Mah C., Hansen J., Zhou S., Dwarki V., et al. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 1999, 5:71-77.
53. Qiu J., Brown K.E. Integrin alphaVbeta5 is not involved in adeno-associated virus type 2 (AAV2) infection. Virology 1999, 264:436-440.
54. Ros C., Gerber M., Kempf C. Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity. J. Virol. 2006, 80:12017-12024.
55. Rosenthal P.B., Henderson R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 2003, 333:721-745.
56. Shen S., Bryant K.D., Brown S.M., Randell S.H., Asokan A. Terminal N-linked galactose is the primary receptor for adeno-associated virus 9. J. Biol. Chem. 2011, 286:13532-13540.
57. Shen S., Bryant K.D., Sun J., Brown S.M., Troupes A., et al. Glycan binding avidity determines the systemic fate of adeno-associated virus type 9. J. Virol. 2012, 86:10408-10417.
58. Sigler P.B., Jeffery B.A., Matthews B.W., Blow D.M. An X-ray diffraction study of inhibited derivatives of alpha-chymotrypsin. J. Mol. Biol. 1966, 15:175-192.
59. Smith T.J., Kremer M.J., Luo M., Vriend G., Arnold E., et al. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 1986, 233:1286-1293.
60. Sonntag F., Bleker S., Leuchs B., Fischer R., Kleinschmidt J.A. Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus. J. Virol. 2006, 80:11040-11054.
61. Sousa D., Grigorieff N. Ab initio resolution measurement for single particle structures. J. Struct. Biol. 2007, 157:201-210.
62. Stewart P.L., Fuller S.D., Burnett R.M. Difference imaging of adenovirus: bridging the resolution gap between X-ray crystallography and electron microscopy. EMBO J. 1993, 12:2589-2599.
63. Stryer L., Kendrew J.C., Watson H.C. The mode of attachment of the azide ion to sperm whale metmyoglobin. J. Mol. Biol. 1964, 8:96-104.
64. Suloway C., Pulokas J., Fellmann D., Cheng A., Guerra F., et al. Automated molecular microscopy: the new leginon system. J. Struct. Biol. 2005, 151:41-60.
65. Summerford C., Samulski R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 1998, 72:1438-1445.
66. Summerford C., Bartlett J.S., Samulski R.J. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat. Med. 1999, 5:78-82.
67. Vihinen-Ranta M., Parrish C.R. Cell infection processes of autonomous parvoviruses. Parvoviruses 2006, 157-163. Hodder Arnold Ltd., London. J.R. Kerr (Ed.).
68. Work L.M., Buning H., Hunt E., Nicklin S.A., Denby L., et al. Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses. Mol. Ther. 2006, 13:683-693.
69. Wu Z., Asokan A., Grieger J.C., Govindasamy L., Agbandje-McKenna M., et al. Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus (AAV) serotypes. J. Virol. 2006, 80:11393-11397.
70. Xie Q., Bu W., Bhatia S., Hare J., Somasundaram T., et al. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. USA 2002, 99:10405-10410.
71. Zhang F., Aguilera J., Beaudet J.M., Xie Q., Lerch T.F., et al. Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus. Biochemistry 2013, 52:6275-6285.